deltatrials
Completed OBSERVATIONAL NCT05880433

The Effects of Mydriatic Eye Drops in Retinopathy of Prematurity Examinations

The Effects of Mydriatic Eye Drops on Cerebral Blood Flow and Oxygenation in Retinopathy of Prematurity Examinations: A Prospective Observational Trial

Sponsor: Istanbul Training and Research Hospital

Conditions Analgesic Adverse Reaction Mydriasis Neonatal Disease Retinopathy of Prematurity
Interventions NIRS(INVOS 5100; Covidien Somanetics, Troy, MI
Updated 4 times since 2023 Last updated: May 19, 2023 Started: May 1, 2021 Primary completion: Nov 30, 2022 Completion: Nov 30, 2022
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Analgesic Adverse Reaction and Mydriasis, this trial is completed. The trial is conducted by Istanbul Training and Research Hospital and has accumulated 4 data snapshots since 2021. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jun 2023 – ~Jul 2024 · 13 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotCompleted~Sep 2025 – present · 10 months · monthly snapshotCompleted

Change History

4 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed

  2. Sep 2024 — Sep 2025 [monthly]

    Completed

  3. Jul 2024 — Sep 2024 [monthly]

    Completed

  4. Jun 2023 — Jul 2024 [monthly]

    Completed

    First recorded

May 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Istanbul Training and Research Hospital
Data source: Istanbul Training and Research Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations